Mucosis BV
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine (NCT02958540) | Mucosis BV | 2016-10-01 |
Track Mucosis BV automatically
Every clearance here is in the API, with alerts when new ones post.